Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Ironwood Pharmaceuticals
IRWD
$626M
| $34.8M | 0.02% |
3,376,180
-3,840,044
| -53% | -$39.3M |
|
577
Palo Alto Networks
PANW
$260B
| $34.6M | 0.02% |
903,396
+7,608
| +0.8% | +$268K |
|
578
American Homes 4 Rent
AMH
$12.2B
| $34.3M | 0.02% |
1,275,443
+1,010,811
| +382% | +$25.2M |
|
579
Roku
ROKU
$21.3B
| $34.2M | 0.02% |
293,494
-175,491
| -37% | -$20.1M |
|
580
Biogen
BIIB
$30.4B
| $34M | 0.02% |
127,047
+47,633
| +60% | +$14.3M |
|
|
SRC
581
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $34M | 0.02% |
975,275
-196,700
| -17% | -$5.96M |
|
582
Pinduoduo
PDD
$122B
| $33.4M | 0.02% |
389,540
-47,110
| -11% | -$2.83M |
|
583
Westlake Corp
WLK
$9.25B
| $33.3M | 0.02% |
621,536
-82,257
| -12% | -$3.79M |
|
584
Vroom Inc
VRM
$36.8M
| $33.3M | 0.02% |
+7,984
| New | +$31M |
|
585
Marathon Petroleum
MPC
$89.3B
| $33.2M | 0.02% |
889,103
-143,182
| -14% | -$4.6M |
|
586
uniQure
QURE
$2.52B
| $33.1M | 0.02% |
735,329
+8,398
| +1% | +$496K |
|
587
Alnylam Pharmaceuticals
ALNY
$38.5B
| $33.1M | 0.02% |
223,661
-183,796
| -45% | -$24.8M |
|
588
Expeditors International
EXPD
$22.4B
| $33M | 0.02% |
434,451
+343,772
| +379% | +$25.1M |
|
589
Philip Morris
PM
$312B
| $32.9M | 0.02% |
469,523
-95,479
| -17% | -$6.96M |
|
590
IPG Photonics
IPGP
$3.57B
| $32.7M | 0.02% |
204,009
+62,855
| +45% | +$8.95M |
|
591
Littelfuse
LFUS
$9.91B
| $32.7M | 0.02% |
191,668
-42,352
| -18% | -$6.43M |
|
|
ONEM
592
DELISTED
1Life Healthcare
ONEM
| $32.7M | 0.02% |
+899,415
| New | +$25.3M |
|
593
Azenta
AZTA
$1.33B
| $32.6M | 0.02% |
+737,327
| New | +$28.2M |
|
|
CDK
594
DELISTED
CDK Global, Inc.
CDK
| $32.4M | 0.02% |
781,161
+22,685
| +3% | +$873K |
|
595
Domino's
DPZ
$11.6B
| $32.3M | 0.02% |
87,560
+50,626
| +137% | +$18.7M |
|
596
Westlake Chemical Partners
WLKP
$776M
| $32.1M | 0.02% |
1,696,261
-121,844
| -7% | -$2.22M |
|
597
TransUnion
TRU
$16.2B
| $32.1M | 0.02% |
368,868
-174,991
| -32% | -$14M |
|
|
EPZM
598
DELISTED
Epizyme, Inc
EPZM
| $32M | 0.02% |
1,994,235
+46,404
| +2% | +$810K |
|
|
CCMP
599
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $31.8M | 0.02% |
+227,660
| New | +$29.5M |
|
600
Linde
LIN
$236B
| $31.4M | 0.02% |
148,025
+48,512
| +49% | +$9.37M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.